That is very important, due to the fact that the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error procedure (biotech stocks). But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. This was an advancement almost no one discovered. However it's going to have profound ramifications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of investment chances in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (brownstone research). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back possibly substantially before going higher - last year. I have actually been covering bitcoin for a long period of time now. Among the very first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were primarily informing readers. But that's not the big question any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a trusted 170-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown genetic sequencing stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of great private companies on the brink of striking the public markets And I've been working on a new method for you to invest even before these companies go public.
This opportunity has been building over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover out all the information. Go right here to reserve your spot for free.
Emma Walsh here, managing editor of the Diary. Routine Diary readers know that tech isn't our typical beat (last week). And when it comes to tech investing, we leave it to the experts. Luckily, we have several such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing professionals we understand (jeff bezos). In reality, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and much more. These trends are experiencing exponential development and developing extraordinary chances for financiers. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. tech predictions. But in spite of what many readers may believe, this is a trend that's just getting going. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still sold.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by two months (longtime readers). Losing 2 months of manufacturing and sales really affects the number of 5G devices are sold in the fiscal year. When you consider all of that, selling 250 million units is amazing. More significantly, the hold-ups brought on by the pandemic created a lot of suppressed need. And that need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be delivered in 2021 - the legacy report predictions. Which's not my only 5G prediction When I have actually discussed 5G in the past, I have actually described its 3 different stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Phase Three, 5G services begin to be provided (biotech stocks). That's when we begin to see applications working on 5G networks. Consider things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Phase 3 by this summer season. This begins something of a virtuous cycle: Many people do not really appreciate the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In truth, 5G is going to open a suite of unbelievable applications: self-driving automobiles, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The investment chances going forward will be huge. Stepping away from 5G, the next essential technology I anticipate in 2021 is CRISPR genetic editing. CRISPR represents "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not operate properly. CRISPR uses a comparable idea but with our genetic code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And throughout that time, there were truly only 3 business operating in this space. However things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this innovation just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire market is efficiently a greenfield opportunity.
There's space for many business to exist in this space. jeff brown predictions 2021. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more genetic modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things happening at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software can accurately forecast the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That's important due to the fact that the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has been a trial-and-error process. Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but a number of drug treatments produced utilizing this technology. This was one of those breakthroughs that practically no one discovered. However it's going to have profound ramifications for curing disease. And, of course, there will be lots of financial investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back maybe considerably before going greater. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin - jeff brown stock predictions. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. However at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. black sea. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date as of February 2021, however we could not separately validate this claim. Provided Jeff Brown's past, he likely has a significant net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to pick winning innovation stocks. He invested more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional point of view on the market. He's always on the hunt for new opportunities, and he shares a lot of his finest picks in the Near Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully anticipated some of the biggest economic occasions of the past twenty years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it ideal every time, but Jeff Brown's precise predictions have made him legions of dedicated fans. That says a lot about his capability. The Future Report is published by Brownstone Research study, a prominent monetary research study publisher. Brownstone Research offers several research study services with a wide array of specializations - jeff brown genome sequencing stock.
The company is likewise affiliated with Bonner & Partners, another well-respected research study publisher - what is the legacy report predicting. On its site, Brownstone states its mission is to provide retail investors with professional-grade research: "For too long, the very best financial investment research has actually not been offered to specific investors. It has actually been usually booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. tech predictions. The objective of Brownstone Research is to make that sort of proprietary research study available to any financiers looking to get an edge in the marketplaces. The objective is basic to provide distinct and successful financial investment research discovered no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he also acts as the firm's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After years of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a little bit about the market, you know that he has a reputation as a King Midas of sorts. the legacy report prediction. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big task.
In truth, Brown thinks S.A.V. future report review. might be "the greatest trend of the 2020s, and he's not alone. Inspect out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be marrying 2 advanced innovations: expert system and electrical automobiles. Musk hopes the combination will assist him develop the first fully-autonomous, self-driving cars and trucks ever. It's nothing short of the vehicle industry's Holy Grail. As you understand, electrical lorries and self-driving vehicle stocks have been big this year, but the Wall Street machine has been big on hype without much tangible outcome. In spite of an extreme boost in competition over the past few years, Brown still thinks Musk has the very best possibility of putting all of it together.
tech could be the magic string that ties everything together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transportation. Essentially, this technology would permit you to rent your car as an autonomous, self-driving taxi when you're not using it. You simply get out of the car and press a button on an app that informs the car to "join the fleet." Next thing you understand, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the revenues. It sounds crazy, but it could be closed than you think.